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Objectives: Catheter-associated urinary tract infection (CAUTI) is the most common device-associated
nosocomial infection worldwide. Bacteria, which exist as a bioﬁlm inside catheters, show higher anti-
microbial resistance when compared to non-CAUTI pathogens. The present study was conducted to
determine the antibiotic susceptibility patterns of CAUTI and non-CAUTI bacteria.
Materials and Methods: The antibiotic susceptibility patterns of 102 uropathogens from noncatheterized
patients and 100 uropathogens from catheterized patients were compared using the disc diffusion
method.
Results: A higher incidence of uropathogens was correlated with catheter use in male patients. Escher-
ichia coli was the predominant isolate obtained from catheterized (81%) and noncatheterized (67%)
patients. This was followed by Pseudomonas aeruginosa, with rates of 28% and 15% in non-CAUTI and
CAUTI patients, respectively. Overall, the E. coli isolates from CAUTI patients showed signiﬁcantly higher
resistance (p < 0.05) than those from non-CAUTI patients against all antibiotics tested, except for
trimethoprim/sulfamethoxazole and gentamicin. Catheter-associated P. aeruginosa isolates showed
signiﬁcantly higher resistance (p < 0.05) against most antibiotics tested compared to non-catheter-
associated isolates.
Conclusion: Uropathogens from CAUTI patients exhibit signiﬁcantly higher resistance to most antibiotics
than non-CAUTI isolates. This is an important factor to take into consideration when choosing correct
treatment options for patients with urinary tract infection.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Urinary tract infection (UTI) is a serious health problem affecting
millions of individuals worldwide. It is estimated that about 150
million cases of UTI occur in the world every year [1e3]. UTI is one
of the most common bacterial infections in many developing
countries, including Bangladesh. UTIs affect all age groups and are
diagnosed in both hospitalized patients and outpatients. This type
of infection causes a serious burden on the socioeconomic life of
individuals and leads to the consumption of a large proportion of all
antibacterial drugs used in the world [4]. Women are more sus-
ceptible to UTIs than men due to the anatomical structure of theiriology, Stamford University
desh. Tel.: þ880 1949622783;
.
elief Tzu Chi Foundation. Publishegenitourinary tract [5]. It has been observed that up to one-third of
all women experience a UTI at some point during their lifetime [6].
The rate of resistance to antibiotics among community-acquired
UTIs is increasing and shows signiﬁcant geographical variations
[7]. Updated knowledge on the diverse etiology of UTIs and the
resistance against antibiotics of the causative organisms is impor-
tant to clinicians when treating such patients.
UTI is the most common infection among patients who have a
chronic indwelling bladder catheter, which may cause bacteriuria
[8e10]. Catheter-associated urinary tract infection (CAUTI) remains
the commonest nosocomial infectionworldwide. It is also the most
common nosocomial infection in hospitals and nursing homes,
accounting for >40% of all institutionally acquired infections [11,12].
The presence of a bioﬁlm plays a central role in the pathogenesis
of CAUTI [13]. CAUTIs are a cause for concern because catheter-
associated bacteriuria comprises a huge reservoir of resistant
pathogens in the hospital environment [14].d by Elsevier Taiwan LLC. All rights reserved.
Table 1
Distribution of infection in the study samples with respect to sex.
Sample type Sex No. of UTI cases % of UTI cases p (z test)a
Noncatheter Female 57 55.88 (a) <0.05 (between a and b)
Male 45 44.12 (b) <0.05 (between b and d)
Total 102 100%
Catheter Female 46 46 (c) <0.05 (between a and c)
Male 54 54 (d) >0.05 (between c and d)
Total 100 100
UTI ¼ urinary tract infection.
a The proportions (%) of males and females were compared using a z test. The level
of signiﬁcance in the two-tailed z-test was set at a ¼ 0.025.
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common pathogenic bacteria present in catheterized and non-
catheterized patients hospitalized in Dhaka city, Bangladesh and to
determine the antibiotic sensitivity patterns of these isolates
against commonly prescribed antibiotics.
2. Materials and methods
2.1. Collection of samples
Urine samples were collected from patients who reported to
Sohrawardi Hospital and Dhaka Medical College Hospital, Dhaka
City, Bangladesh. Two types of patients, with and without an
indwelling catheter, were included in this study when they re-
ported to the abovementioned hospitals. In case of noncatheterized
patients, mid-stream urine samples were collected. Among the
catheterized patients, the help of a health technicianwas needed to
collect the urine sample.
2.2. Isolation of pathogenic bacteria
A measured loop was used to streak 10 mL of each sample
separately on blood agar and MacConkey agar plates, which were
then incubated at 37C overnight. Suspected bacterial colonies
were identiﬁed using standard biochemical tests. All samples with
a bacteriuria of >104 colony-forming units/mL urine of one or two
organismswere analyzed to determine the causative uropathogens.
From a total of 202 samples, 102 uropathogens were isolated from
noncatheterized patients and 100 from catheterized patients.
2.3. Biochemical identiﬁcation of isolated bacteria
Isolates were identiﬁed by standard biochemical tests, including
the oxidase test, the Simmon's citrate agar test, the motility iodole
urease test, growth on Kligler's iron agar, the coagulase test, and the
catalase test [15].
2.4. Antibiotic sensitivity test
Three to ﬁve well-isolated colonies were transferred into a tube
containing 4e5 mL of Trypticase Soy Broth (TSB, Oxoid, UK) and
incubated at 35C until the turbidity reached the 0.5 McFarland
standard. A sterile cotton swab was dipped into the adjusted sus-
pension. The dried surface of a MüellereHinton agar plate was
inoculated by streaking the swab over the entire sterile agar surface.
Commercially available antibiotic discs were used, namely amikacin
30 mg, ciproﬂoxacin 5 mg, clindamycin 2 mg, rifampicin 5 mg, cefur-
oxime 30 mg, trimethoprim/sulfamethoxazole 1.25/23.75 mg, eryth-
romycin 15 mg, gentamycin 10 mg, penicillin 10 units, amoxicillin
500 mg, amoxicillin/clavulanate 20/10 mg, ceﬁxime 30 mg, cefeprime
30 mg, vancomycin 30 mg, linezolid 30 mg, ceftriaxone 30 mg, cefta-
zidine 30 mg, meropenem 10 mg, pipercillinetazobactam 100/10 mg,
nitrofurantoin 300 mg, carbenicillin 100 mg, tobramycin 10 mg,
aztreonam 30 mg, and colistin 10 mg, all with a correct diameter and
potency. Stocks of antibiotic discs were stored at 20C. The plates
were incubated at 35C for 18e24 hours. The sizes of the zones of
inhibition were interpreted according to the Clinical Laboratory
Standards Institute guidelines (2011).
2.5. Novobiocin disc sensitivity test
Colonies from a pure culture diluted into TSB to a 0.5 McFarland
standard was inoculated by swabbing on MüellereHinton agar.
When the surface was dry, a novobiocin disc was placed in the
center. The plate was incubated for 24 hours at 37C. A zone size16mm indicates resistance to novobiocin. A zone size of 17mm or
larger indicates susceptibility to novobiocin [16].
2.6. Statistical analysis
Statistical analysis was carried out using the online software
available at http://www.socscistatistics.com/. Tests of proportions
were performed using the z test. The level of signiﬁcance in the
two-tailed z test was set at a ¼ 0.025.
3. Results
A total of 202 samples, 102 from noncatheterized patients with
UTI (Category A, non-CAUTI) and 100 from catheterized patients
with UTI (Category B, CAUTI), were included in this study to
determine any signiﬁcant correlation between the drug resistance
patterns of these two groups. The ages of participants ranged from
1.5 years to 89 years for the former category and from 15 years to 85
years for the latter category.
3.1. Distribution of UTI across the two sexes
Table 1 depicts the occurrence of the isolates across the two
genders. A signiﬁcant difference was found with respect to the
occurrence of antibiotic-resistant pathogens between males and
females in the noncatheterized group (p < 0.05), with females
having a greater incidence rate than males. By contrast, there was
no signiﬁcant difference between the occurrence of multidrug
resistant (MDR) uropathogens in males and females in the cathe-
terized group (p> 0.05). A signiﬁcantly higher incidence of UTI with
MDR uropathogens was observed in females who were non-
catheterized than in those who were catheterized (p < 0.05). By
contrast, males who were catheterized showed a signiﬁcantly
higher occurrence of MDR uropathogens than those who were not
catheterized (p < 0.05).
3.2. Presence of pathogenic bacteria in CAUTI and non-CAUTI
patients
The overall distribution of the uropathogens is presented in
Fig. 1A and B for non-CAUTI and CAUTI patient samples, respec-
tively. In both cases, E. coliwas the predominant isolate, making up
67% and 81% of the total isolates from non-CAUTI and CAUTI pa-
tients, respectively. This was followed by P. aeruginosa, which was
found in 28% and 15% of the total isolates from the non-CAUTI and
CAUTI patients, respectively. Gram-positive organisms made up
only 2% and 3% of the total isolates from the non-CAUTI and CAUTI
patients, respectively (Fig. 1A and B). Streptococcus agalactiae was
isolated only from noncatheterized patients, and Staphylococcus
saprophyticus was unique to catheterized patients.
The two predominant isolates, E. coli and P. aeruginosa, were
tested for their susceptibility pattern to 11 commonly used
Fig. 1. Distribution of uropathogens in the clinical samples from (A) non-CAUTI and (B)
CAUTI patients. CAUTI ¼ catheter-associated urinary tract infection; UTI ¼ urinary tract
infection.
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showed signiﬁcantly higher resistance than those from the non-
CAUTI patients when tested against all antibiotics, except for
amikacin (Table 2). In contrast to E. coli, catheter-associated
P. aeruginosa showed signiﬁcantly higher resistance among the
non-catheter-associated isolates when tested against all antibi-
otics (Table 2).Table 2
Antibiotic resistance patterns of Escherichia coli and Pseudomonas aeruginosa isolates fro
Antibiotic Resistant/total isolate (%) of E. coli
CAUTI Non-CAUTI
Amikacin 14/81 (17.28) 35/68 (51.47)
Amoxicillin/clavulanate 68/79 (86.07) 38/68 (55.88)
Azithromycin 20/32 (62.5) 22/48 (45.83)
Ceﬁxime 60/80 (75.00) 44/70 (62.86)
Ceftazidime 61/81 (75.31) 37/67 (55.22)
Ceftriaxone 57/81 (70.37) 35/68 (51.47)
Ciproﬂoxacin 46/74 (62.62) 32/68 (47.05)
Trimethoprim/sulfamethoxazole 52/81 (64.19) 35/69 (50.72)
Doxycycline 53/80 (66.25) 38/69 (55.07)
Gentamicin 35/64 (54.68) 34/68 (50.00)
Meropenem 14/23 (60.87) 1/6 (14.29)
CAUTI ¼ catheter-associated urinary tract infection.
a The proportions of antibiotic resistance (%) were compared between the catheter- and
tailed z test was set at a ¼ 0.025.3.3. Distribution of MDR bacteria across different age groups of
CAUTI and non-CAUTI patients
MDR E. coli and P. aeruginosa were present among isolates
belonging to all age groups (Figs. 2A, B and 3A, B). The highest
number of MDR E. coli was found in the age group of 21e30 years
for both catheterized and noncatheterized patients. The highest
proportion of MDR P. aeruginosawas found in CAUTI-patients aged
21e30 years, and a similar trend was observed for E. coli. However,
the number of MDR P. aeruginosa isolates was highest among
31e40-year-old noncatheterized patients.3.4. Occurrence of MDR bacteria in CAUTI and non-CAUTI patients
Resistance against 10 antibiotics was found to occur at a rate of
1% among the 70 catheter-associated E. coli isolates. Of the MDR
isolates from the same category, 7% were resistant to a minimum of
two antibiotics (cefexime and ciproﬂoxacin) tested. A maximum
of 26% of the isolates from this group was resistant to seven out
of the 10 antibiotics tested. Among the catheter-associated
P. aeruginosa isolates, resistance to a maximum of 10 and to a
minimum of two antibiotics (cefexime and ceftazidime) was also
examined. A maximum of 27% (n ¼ 15) of P. aeruginosa isolates was
resistant to nine antibiotics and a corresponding a minimum of 7%
was found to be resistant to two of the antibiotics tested. In case of
non-CAUTI E. coli isolates, resistance to a maximum of 10 and a
minimum of two antibiotics (cefexime and ciproﬂoxacin) was
observed; the highest proportion of MDR E. coli in noncatheterized
patients was 36% (resistant to 4 antibiotics) and the lowest was 2%
(resistant to 2 antibiotics). In case of P. aeruginosa from the same
source, resistance to up to 10 antibiotics was observed in 7% (n ¼ 9)
of the isolates. The maximum and minimum proportions of MDR
P. aeruginosawere 21% and 7%, which were resistant to three and 10
antibiotics, respectively.4. Discussion
UTI is considered to be a common health problem and inﬂicts
150million peopleworldwide every year [1]. Infections may ormay
not be associated with the use of a catheter. The urinary catheter is
one of the most frequently used invasive medical devices. Patient
exposure may be exceedingly short, involving only a single cathe-
terization, or may be continued for years in individuals with
chronic indwelling catheters. Bioﬁlm formation along the catheter
means that bacteriuria develops in a predictable manner if them catheterized and noncatheterized patients.
pa Resistant/total isolate (%) of
P. aeruginosa
pa
CAUTI Non-CAUTI
<0.05 6/15 (40.00) 6/28 (21.43) <0.05
<0.05 12/14 (85.71) 24/28 (85.71) <0.05
<0.05 2/3 (66.67) 8/19 (42.11) <0.05
<0.05 15/15 (100) 20/28 (71.42) <0.05
<0.05 11/15 (73.33) 17/28 (60.71) <0.05
<0.05 11/15 (73.33) 17/28 (60.71) <0.05
<0.05 10/13 (76.92) 14/28 (50.00) <0.05
<0.05 13/15 (86.66) 19/27 (70.37) <0.05
<0.05 12/15 (80.00) 17/26 (65.38) <0.05
<0.05 8/15 (53.33) 13/29 (44.83) <0.05
<0.05 6/6 (50.00) 7/21 (33.33) <0.05
noncatheter-associated isolates using the z test. The level of signiﬁcance in the two-
Fig. 3. Distribution of (A) MDR Escherichia coli and (B) MDR Pseudomonas aeruginosa
among catheterized and noncatheterized patients. MDR ¼ multidrug resistant.
Fig. 2. Distribution of (A) MDR Escherichia coli and (B) MDR Pseudomonas aeruginosa in
the urinary tract infection samples. MDR ¼ multidrug resistant.
M.D. Hossain et al. / Tzu Chi Medical Journal 26 (2014) 127e131130indwelling catheter remains in situ. However, symptomatic infec-
tion is relatively uncommon among patients who are being
managed with short-term catheters. The patterns of antimicrobial
resistance associated with UTI vary across the different regions of
the world. UTI is common in Bangladesh and has been reported to
affect all age groups of individuals, both hospitalized patients and
outpatients [17].
The occurrence of antibiotic-resistant pathogens at a higher
frequency in females than in males may be due to the fact that
females are more susceptible to UTI because of their anatomy than
males, irrespective of the use of a catheter [5,6]. No signiﬁcant
difference was observed between the occurrence of MDR uro-
pathogens in males and females of the catheterized group
(p > 0.05). Additionally, males who were catheterized showed a
signiﬁcantly higher occurrence of MDR uropathogens than those
who were not catheterized (p < 0.05). The higher incidence of MDR
uropathogens in males who were catheterized compared to the
incidence in either females or males in the other category possibly
indicates the effect of catheterization on the presence of MDR
isolates. A catheter provides an artiﬁcial surface for bioﬁlm for-
mation, and this has been reported to bring about increased drug
resistance [13,14,18]. However, a similar effect was not evident in
females. In this study, the incidence of MDR bacteria was signiﬁ-
cantly higher (p > 0.05) among noncatheterized patients in the age
group of 1e40 years. This was different from the situation among
catheterized patients, where the pattern showed a signiﬁcantly
higher incidence in the age group of 41e90 years (p > 0.05). This
could be due to the administration of antibiotics during catheter
use.
The types of uropathogens examined in this study varied
slightly between the noncatheterized and catheterized patients.
Among the non-catheter-associated isolates E. coli was the most
predominant uropathogen (67%), followed by Pseudomonas spp.
(28%), Klebsiella pneumoniae (1%), and S. agalactiae (2%). Amongthe catheter-associated isolates, E. coli again was the major
pathogen (81%), followed by Pseudomonas spp. (15%), S. agalactiae
(2%), and K. pneumoniae (1%). The prevalence of uropathogenic
organisms has been found to be remarkably consistent, with
Gram-negative organisms accounting for most infections [19]. A
number of other studies have also found that E. coli is usually the
predominant uropathogen, for example, E. coli made up 70% of
isolates in a study conducted in India [13], 38.7% in a study con-
ducted in Korea [20], 31.5% in a study conducted in Tamil Nadu,
India [21], 21.5% in a study conducted in Nigeria [22], 53.24% in a
study conducted in South Jordan [23], 80% in a study conducted in
Canada [24], and 74% in a study conducted in Bangladesh [25].
Baron et al [26] also reported that E. coli is the most common
organism associated with UTI with respect to both community-
acquired and hospitalized cases. In accordance with the present
investigation, another recent study conducted in Bangladesh has
also found E. coli to be the major pathogen associated with UTI
[17].
The rate of UTI, particularly that caused by E. coli, was higher in
patients of reproductive age (21e30 years) irrespective of cathe-
terization. A higher percentage of P. aeruginosa was also found
among catheterized patients in the same age group. Similar ﬁnd-
ings have been reported in other studies [17,27,28] conducted in
Bangladesh, as well as elsewhere in the world [29]. The high
occurrence of UTI at this age may be due to the initial exposure of
these people to sex and a lack of sufﬁcient knowledge of hygiene
practices [17].
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infections caused by microorganisms. Resistance to antimicrobials
has increased over the years. Resistance rates vary from country to
country [30,31]. Overall, isolates from Latin American countries
have shown the highest resistance rates against all antimicrobial
agents, followed by Asian-Paciﬁc isolates and European strains,
whereas the strains from Canada exhibit the lowest resistance
pattern [30,31]. In this study, antibiotic resistance was signiﬁcantly
higher among catheterized patients than among noncatheterized
patients for both E. coli and P. aeruginosa (p < 0.05). Previous studies
conducted in Bangladesh also indicated increasing resistance of
uropathogens to most antibiotics [17,27,32e34]. As with the pre-
sent study, a pattern of higher resistance was observed for CAUTI
uropathogens than for non-CAUTI isolates [13,35].
With regard to the treatment of UTI, the optimal duration of
antimicrobial therapy is still an unresolved question [36]. Levo-
ﬂoxacin has been suggested to be as effective for clinical outcomes
as ciproﬂoxacin at the right dose [37]. The efﬁcacy of beta-lactam
antibiotics has not been investigated adequately. They are said to
be less effective than trimethoprim. Quinolones and nitrofurantoin
require further study prior to when any conclusion can be drawn
with regard to their treatment efﬁcacy [38]. In the present study, all
the E. coli isolates from CAUTI cases showed resistance to all anti-
biotics tested, except amikacin. In case of P. aeruginosa, all the
catheter-associated isolates exhibited resistance to all antibiotics
tested. Based on the present study, uropathogens from CAUTI and
non-CAUTI patients showed variations in their resistance pattern to
different antimicrobials, indicating that the same treatment cannot
be applied to all cases. The antibiogram also varies depending on
the causative organism. From the present study, it appears that new
guidelines and treatment regimens need to be identiﬁed for UTI
patients irrespective of catheter use. Whether levoﬂoxacin or cip-
roﬂoxacin can still remain the antimicrobial of choice for effective
treatment of UTI remains enigmatic. It is expected that the results
from studies similar to the present research will aid in the devel-
opment of guidelines for the prevention of UTIs. With emerging
knowledge on antibiotic resistance and health care-associated
infection, guidelines need to be updated to reﬂect the need to
prescribe narrow-spectrum agents when available and avoid
empirical use of broad-spectrum antibiotics.
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